Orion OYJ (OTCMKTS:ORINY) Sets New 52-Week High – Here’s What Happened

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY)’s share price reached a new 52-week high during trading on Friday. The stock traded as high as $47.6750 and last traded at $47.6750, with a volume of 195 shares. The stock had previously closed at $46.00.

Orion OYJ Trading Up 3.6%

The stock has a market cap of $13.46 billion, a PE ratio of 19.62 and a beta of 0.08. The firm has a 50-day moving average price of $44.30 and a 200-day moving average price of $40.59. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.48 and a current ratio of 2.64.

Orion OYJ (OTCMKTS:ORINY) last announced its quarterly earnings data on Friday, July 17th. The company reported $0.58 EPS for the quarter. The company had revenue of $606.38 million for the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 50.37%.

About Orion OYJ

Orion Oyj is a Finland-based pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes proprietary prescription treatments, generic medicines, consumer health products and pharmaceutical active ingredients.

The company focuses its research and commercial activities on areas including central nervous system disorders, oncology, respiratory diseases, veterinary medicine and pain management. Orion also works with international pharmaceutical companies through licensing, development and commercialization partnerships.

Founded in 1917, Orion is headquartered in Espoo, Finland, and serves customers through operations and partnerships in Finland, Europe and other international markets.